clinical trials

AbbVie preps JAK atopic dermatitis candidate for phase 3
Fierce Biotech
Sun, 09/10/17 - 11:56 am
AbbVie
JAK inhibitors
clinical trials
atopic dermatitis
Upadacitinib
Sanofi
Regeneron
Dupixent
Eli Lilly says late-stage, 12-month study showed its migraine treatment was safe, effective
Marketwatch
Fri, 09/8/17 - 09:44 am
Eli Lilly
migraines
clinical trials
galcanezumab
FDA orders Bristol-Myers’ Opdivo to the sidelines on 3 studies as regulators explore dangers of checkpoint combos
Endpoints
Wed, 09/6/17 - 08:57 pm
FDA
Bristol-Myers Squibb
Opdivo
clinical trials
Multiple Myeloma
Verastem bet on blood cancer drug pays off with trial success
BioPharma Dive
Wed, 09/6/17 - 08:31 pm
Verastem
clinical trials
duvelisib
Insmed shares soar as PhIII lung disease study proves positive, pointing to quick FDA pitch
Endpoints
Tue, 09/5/17 - 10:16 pm
Insmed
clinical trials
Arikayce
ALIS
Can marketing techniques save clinical trials?
Medical Marketing and Media
Tue, 09/5/17 - 11:26 am
patients
clinical trials
clinial trial recruitment
Patient Death Triggers FDA Hold For Cellectis’s “Off the Shelf” CAR-T
Xconomy
Tue, 09/5/17 - 09:50 am
FDA
Cellectis
CAR-T
UCART123
clinical trials
Top FDA trial expert Richard Moscicki jumps to a senior post at PhRMA
Endpoints
Thu, 08/31/17 - 09:14 am
FDA
clinical trials
Richard Moscicki
PhRMA
Boehringer Ingelheim/Pharmaxis start Phase IIa trial in NASH
GoInPharma
Wed, 08/30/17 - 11:45 pm
Boehringer Ingelheim
Pharmaxis
NASH
clinical trials
BI 1467335
Otonomy staggered by an ugly PhIII failure for lead pipeline drug
Endpoints
Wed, 08/30/17 - 11:08 am
Otonomy
clinical trials
Otividex
Meniere's Disease
Peter Thiel funds offshore test of herpes vaccine, evading U.S. safety regulations
Stat
Mon, 08/28/17 - 09:42 am
Peter Thiel
vaccines
herpes
clinical trials
Medtronic readies pivotal trial in renal denervation
Mass Device
Mon, 08/28/17 - 09:37 am
Medtronic
renal denervation
devices
hypertension
clinical trials
Genmab gains on promising early success for daratumumab PhIII in multiple myeloma, but questions linger
Endpoints
Fri, 08/25/17 - 09:49 am
Genmab
daratumumab
Darzalex
Multiple Myeloma
clinical trials
Bioverativ taps patient social network for input on hemophilia trial design
Fierce Pharma
Thu, 08/24/17 - 10:41 pm
Bioverativ
social media
clinical trials
patients
hemophilia A
Biogen
Patients Not Always Informed of Study's Purpose in Noninferiority Trials
RAPS.org
Thu, 08/24/17 - 05:12 pm
patients
noninferiority trials
antibiotics
clinical trials
Ultragenyx shelves genetic disease drug after trial failure
BioPharma Dive
Wed, 08/23/17 - 10:08 pm
Ultragenyx
clinical trials
Ace-ER
Novogen irons out Phase 2 plans for brain cancer candidate
BioPharma Dive
Wed, 08/23/17 - 11:12 am
Novagen
clinical trials
GDC-0084
glioblastoma multiforme
brain cancer
Will third trial be the charm for Alkermes' depression drug?
Fierce Biotech
Tue, 08/22/17 - 12:04 am
Alkermes
clinical trials
ALKS 5461
major depressive disorder
Drug developers face increasingly risky tightrope walk between top-line results and hard data
Endpoints
Tue, 08/15/17 - 10:57 am
drug development
clinical trials
late stage data
Roche
Perjeta
FDA gives OK, Cel-Sci clinical hold finally lifted
BioPharma Dive
Tue, 08/15/17 - 09:29 am
FDA
Cell-Sci
Multikine
clinical trials
head and neck cancer

Pages